PRE-MARKET MOVERS

 

UPGRADES

2. BIIB:$BIIB upgraded to Overweight at PiperJaffray
7. CYBR:$CYBR upgraded to Outperform at Imperial Capital – PT $55
14. TWX:$TWX upgraded to Outperform at Credit Suisse – PT $107.50

 

DOWNGRADES

5. GPRO:$GPRO downgraded to Underperform at Bank of America
6. TEVA:$TEVA downgraded to Neutral at Bank of America

 

EARNINGS

 

Trending Social Alerts

3. NILE:$NILE -10% on Friday; acquired by Bain at $40.75 on Monday. The game is hard
4. N:$N Halted, news pending
6. CXRX:Concordia misses estimates by wide margin $0.69 vs $1.04 expected Will no longer provide financial forecasts $CXRX $CXR.TO

 

Trending News Headlines

1. Cempra antibiotic approval still in doubt even with positive fda panel vote

By a slim 7-6 margin, experts convened by the FDA decided the benefits of solithromycin outweighed its potential safety problems in treating patients with community-acquired bacterial pneumonia.

2. MGM Resorts (MGM) Tops Q3 EPS Views; MGM China Revenue Sank 6%

MGM Resorts (NYSE: MGM) reported Q3 EPS of $0.53, $0.42 better than the analyst estimate of $0.11. Revenue for the quarter came in at $2.52 billion versus the consensus estimate of $2.38…

3. Banks Passed Up Uber Share Sale on Lack of Data

The potential fees and reputation boost that could come from working on Uber Technologies Inc.’s initial public offering are the stuff of bankers’ dreams.

4. Biotech portfolio updates – ESMO 2016, Exelixis, Abeona, Esperion and Seattle Genetics | Open Reading Frame

After a two-month break here is a recap of key highlights from the September/October time frame. On the menu today: PD-1 controversies at ESMO 2016, Exelixis’ ( EXEL ) launch in renal cancer, gene therapy data from Abeona ( ABEO ), long awaited update from Esperion ( ESPR ) and a positive surprise from Seattle Genetics ( SGEN ).

5. FDA panel, by a whisker, votes yes on Cempra’s antibiotic | FierceBiotech

An FDA panel has voted 7-6 that Cempra’s new antibiotic solithromycin should be recommended for U.S. regulatory approval–coming days after its shares plummeted by 40% on safety fears.

6. Bain Capital, Bow Street-Led Investor Group to Acquire Blue Nile (NILE) for $40.75/Share

Leading online jeweler Blue Nile (Nasdaq: NILE), announced that it has entered into a definitive agreement to be acquired by an Investor Group comprised of funds managed by…

7. Meg Tirrell on Twitter

“Piper’s Schimmer lists collusion focus potentially shifting to MS as risk in $BIIB upgrade”

8. Windstream (WIN), EarthLink (ELNK) Enter $1.1B Merger Agreement

Windstream Holdings, Inc. (Nasdaq: WIN) and EarthLink Holdings Corp. (Nasdaq: ELNK) announced that their boards of directors have unanimously approved a definitive merger…

Technology News

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Share This

Share this post with your friends!